Jin Medical International (ZJYL) Equity Ratio (2022 - 2025)

Jin Medical International's Equity Ratio history runs 4 years deep, the most recent figure standing at 0.06 for Q3 2025.

• In Q3 2025, Equity Ratio fell 91.11% year-over-year to 0.06; the TTM figure through Sep 2025 stood at 0.06 (down 84.72% YoY), while the FY2025 annual figure was 0.06, down 91.11% from the prior year.
• Equity Ratio came in at 0.06 for Q3 2025 at Jin Medical International, down from 0.62 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.73 in Q3 2023 to a low of 0.06 in Q3 2025.
• A 4-year average of 0.53 and a median of 0.68 in 2022 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio gained 0.16% in 2023 and tumbled 91.11% in 2025, its largest moves.
• Jin Medical International's Equity Ratio stood at 0.73 in 2022, then advanced by 0.16% to 0.73 in 2023, then declined by 14.46% to 0.62 in 2024, then sank by 91.11% to 0.06 in 2025.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.06, 0.62, and 0.73 for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison